Moderna Inc. (MRNA) - 5i Research

Moderna Inc. (MRNA $27.16)
- $27.16 Cap: $10.56B
- View MRNA Profile
- View Questions on MRNA

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $298.43)
- $298.43 P/E (TTM): 24.38X Cap: $160.66B
- View AMGN Profile
- View Questions on AMGN
CVS Health Corporation (CVS $78.15)
- $78.15 P/E (TTM): 205.66X Cap: $99.20B
- View CVS Profile
- View Questions on CVS
Johnson & Johnson (JNJ $188.87)
- $188.87 P/E (TTM): 18.23X Cap: $454.86B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $90.70)
- $90.70 P/E (TTM): 25.06X Cap: $116.33B
- View MDT Profile
- View Questions on MDT
Moderna Inc. (MRNA $27.16)
- $27.16 Cap: $10.56B
- View MRNA Profile
- View Questions on MRNA

Q: I am building a diversified portfolio of healthcare stocks. I own JNJ, AMGN, MDT, CVS and MRNA. These are 2.9%, 3.8%, 2.5%, 4% and 0.5% of my portfolio respectively. Is this a high quality portfolio? Would you recommend any changes?

Read Answer Asked by David on October 08, 2025

Amgen Inc. (AMGN $298.43)
- $298.43 P/E (TTM): 24.38X Cap: $160.66B
- View AMGN Profile
- View Questions on AMGN
PayPal Holdings Inc. (PYPL $69.27)
- $69.27 P/E (TTM): 13.94X Cap: $64.81B
- View PYPL Profile
- View Questions on PYPL
AbbVie Inc. (ABBV $218.04)
- $218.04 P/E (TTM): 104.33X Cap: $385.18B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $862.86)
- $862.86 P/E (TTM): 42.21X Cap: $815.73B
- View LLY Profile
- View Questions on LLY
Progressive Corporation (The) (PGR $206.00)
- $206.00 P/E (TTM): 11.61X Cap: $120.75B
- View PGR Profile
- View Questions on PGR
Prologis Inc. (PLD $124.09)
- $124.09 P/E (TTM): 36.07X Cap: $115.26B
- View PLD Profile
- View Questions on PLD
Moderna Inc. (MRNA $27.16)
- $27.16 Cap: $10.56B
- View MRNA Profile
- View Questions on MRNA
Enphase Energy Inc. (ENPH $30.51)
- $30.51 P/E (TTM): 20.9X Cap: $3.99B
- View ENPH Profile
- View Questions on ENPH
BioNTech SE (BNTX $103.91)
- $103.91 Cap: $24.93B
- View BNTX Profile
- View Questions on BNTX

Q: Given the potential for a market down-turn, do you see any of these as a good buy for a long-term investment?

Read Answer Asked by Camille on August 01, 2025

Abbott Laboratories (ABT $123.62)
- $123.62 P/E (TTM): 15.51X Cap: $214.95B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $862.86)
- $862.86 P/E (TTM): 42.21X Cap: $815.73B
- View LLY Profile
- View Questions on LLY
Pfizer Inc. (PFE $24.65)
- $24.65 P/E (TTM): 13.11X Cap: $140.14B
- View PFE Profile
- View Questions on PFE
Novo Nordisk A/S (NVO $49.46)
- $49.46 P/E (TTM): 14.04X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Moderna Inc. (MRNA $27.16)
- $27.16 Cap: $10.56B
- View MRNA Profile
- View Questions on MRNA

Q: Hello,

Given the current price levels of both MRNA and PFE would this be a good time to take position in either one of those? If so which one would you recommend.

Thank you!

Read Answer Asked by Irek on February 14, 2025